US biopharma AbbVie has signed an agreement to acquire US biotechnology company Nimble Therapeutics, including its lead asset, an investigational oral peptide IL23R...
04.04.2017
- Germany’s Merck KGaA has entered a collaboration agreement with UK drug development company Avillion to develop its anti IL-17 A/F Nanobody as a treatment for plaque psoriasis, a...
21.05.2015
- Johnson & Johnson's Janssen Pharmaceuticals offshoot has told analysts it plans to seek regulatory approval for more than 10 new drugs up to 2019, each with the potential to...
24.02.2015
- French drugmaker Sanofi and Dutch biotech Lead Pharma have entered a research collaboration and license agreement to discover, develop and commercialize small-molecule therapies...
